Reconstituted Dry Powder Formulations of ZnO-Adjuvanted Ovalbumin Induce Equivalent Serum Antibody Responses to Ovalbumin Adjuvanted with Alhydrogel® or Cationic Adjuvant Formulation 01 (Caf®01)
Research output: Working paper › Preprint › Research
Documents
- Fulltext
Submitted manuscript, 1.75 MB, PDF document
Original language | English |
---|---|
Number of pages | 41 |
DOIs | |
Publication status | Published - 2023 |
Series | SSRN Electronic Journal |
---|
Bibliographical note
Funding declaration: We acknowledge the support from the NordicPOP (patient-oriented products) consortium funded by the NordForsk program Nordic University Hub (grant number 85352) and the Independent Research Fund Denmark (grant numbers 4184-00422 and 9041-00198B to CF). MH was supported by the NordicPOP mobility grant, and AT was supported by the Independent Research Fund Denmark grants.
Conflict of Interests: DC was employed by Statens Serum Institut, Denmark, which is a non-profit government research facility, of which the CAF® adjuvants are proprietary products. The other authors involved in this study have no conflicts of interest.
Ethical Approval: All experimental work with mice was approved by the Danish National Experiment Inspectorate under permit 2016-15-0201-01026 and was performed in accordance with the European Community directive 86/609 for the care and use of laboratory animals.
Number of downloads are based on statistics from Google Scholar and www.ku.dk
ID: 359722642